Immunoglobulin Market Size To Grow USD 24.98 Billion by 2032

According to a recent research report titled “Immunoglobulin Market (By Application: Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain‐Barré Syndrome, Others; By Product: IgA, IgG, IgM, IgE, IgD; By Mode of Delivery: Intravenous, Subcutaneous) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global immunoglobulin market size is projected to touch around USD 24.98 billion by 2032 and growing at a CAGR of 7.20% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the immunoglobulin market.

Key Takeaways

• North America contributed more than 46% market share in 2022.
• Asia-Pacifica is estimated to witness the fastest CAGR between 2023 and 2032.
• By application, the hypogammaglobulinemia segment has held the largest market share of 38% in 2022.
• By application, the immunodeficiency disease segment is anticipated to grow at a remarkable CAGR of 9.1% between 2023 and 2032.
• By product, the IgA segment generated over 41% of market share in 2022.
• By product, the IgG segment is expected to expand at the fastest CAGR over the projected period.
• By mode of delivery, the Intravenous segment had the largest market share of 66% in 2022.
• By mode of delivery, the subcutaneous segment is expected to expand at the fastest CAGR over the projected period.

The report primarily focuses on the volume and value of the immunoglobulin market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.

Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3646

The research also highlights significant progressions in both organic and inorganic growth strategies within the global immunoglobulin market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the immunoglobulin market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.

Immunoglobulin Market Scope

Also read: Human Augmentation Market Size to Record US$ 1,117.53 billion by 2032

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the immunoglobulin market.

Recent Developments

• In 2023, Everest Medicines gained approval from the Hainan Medical Products Administration for clinical use of Nefecon, a primary immunoglobulin A nephropathy (IgAN) drug, in China. This milestone marks progress in addressing IgAN, a condition affecting the kidneys, enhancing treatment options for patients in the region.
• In 2022, Grifols secured approval from European Union member state health authorities and the United Kingdom for XEMBIFY, a groundbreaking 20% subcutaneous immunoglobulin (SCIG). This innovative treatment is authorized for addressing primary and specific secondary immunodeficiency, marking a significant advancement in therapeutic options for these conditions.
• In 2021, Octapharma USA’s investigational new drug (IND) application for a phase three clinical trial assessing the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in severe COVID-19 patients received authorization from the U.S. Food and Drug Administration (FDA).

Immunoglobulin Market Players

• Grifols, S.A.
• Shire
• CSL Behring
• Kedrion S.p.A.
• Octapharma
• Baxter International Inc.
• Biotest AG
• Bio Products Laboratory Ltd. (BPL)
• China Biologic Products Holdings, Inc.
• LFB SA
• Cangene Corporation
• Bharat Serums and Vaccines Limited
• Takeda Pharmaceutical Company Limited
• Bio Products Laboratory Ltd. (BPL)
• China National Pharmaceutical Group Corporation (Sinopharm)

Segments Covered in the Report

By Application

• Hypogammaglobulinemia
• Chronic Inflammatory Demyelinating Polyneuropathy
• Immunodeficiency Disease
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• Idiopathic Thrombocytopenic Purpura
• Inflammatory Myopathies
• Specific Antibody Deficiency
• Guillain‐Barré Syndrome
• Others

By Product

• IgA
• IgG
• IgM
• IgE
• IgD

By Mode of Delivery

• Intravenous
• Subcutaneous

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Table of Content:

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoglobulin Market 

5.1. COVID-19 Landscape: Immunoglobulin Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoglobulin Market, By Application

8.1. Immunoglobulin Market, by Application, 2023-2032

8.1.1 Hypogammaglobulinemia

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Chronic Inflammatory Demyelinating Polyneuropathy

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Immunodeficiency Disease

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Myasthenia Gravis

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Multifocal Motor Neuropathy

8.1.5.1. Market Revenue and Forecast (2020-2032)

8.1.6. Idiopathic Thrombocytopenic Purpura

8.1.6.1. Market Revenue and Forecast (2020-2032)

8.1.7. Inflammatory Myopathies

8.1.7.1. Market Revenue and Forecast (2020-2032)

8.1.8. Specific Antibody Deficiency

8.1.8.1. Market Revenue and Forecast (2020-2032)

8.1.9. Guillain Barre Syndrome

8.1.9.1. Market Revenue and Forecast (2020-2032)

8.1.10. Others

8.1.10.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Immunoglobulin Market, By Product

9.1. Immunoglobulin Market, by Product, 2023-2032

9.1.1. IgA

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. IgG

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. IgM

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. IgE

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. IgD

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Immunoglobulin Market, By Mode of Delivery 

10.1. Immunoglobulin Market, by Mode of Delivery, 2023-2032

10.1.1. Intravenous

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Subcutaneous

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Immunoglobulin Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Mode of Delivery (2020-2032)

Chapter 12. Company Profiles

12.1. Grifols, S.A.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Shire

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. CSL Behring

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Kedrion S.p.A.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Octapharma

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Baxter International Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Biotest AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Bio Products Laboratory Ltd. (BPL)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. China Biologic Products Holdings, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. LFB SA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global immunoglobulin market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for immunoglobulin. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

• What is the size of the overall Immunoglobulin market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the Immunoglobulin market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Immunoglobulin market?
• What is the Immunoglobulin market size at the regional and country-level?
• Who are the key market players and their key competitors?
• What are the strategies for growth adopted by the key players in Immunoglobulin market?
• What are the recent trends in Immunoglobulin market? (M&A, partnerships, new product developments, expansions)?
• What are the challenges to the Immunoglobulin market growth?
• What are the key market trends impacting the growth of Immunoglobulin market?

 

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

---